MECP2 and neurodevelopmental disorder: Inhibition of PTP1B eliminated repetitive behaviors and improved motor function in MeCP2-deficient mice27, suggesting that a severe neurodevelopmental disorder could be ameliorated by postnatal pharmacological intervention targeting PTP1B.